Caring for patients and families at their most vulnerable is a true privilege that inspires me to provide the best possible care.
Where I see patients (2)
Selected research
-
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.
Lancet (London, England)
-
Expansion of outer cortical CUX2 neurons requires adaptations for DNA repair.
Nature
-
Mechanical Thrombectomy Access Score: A Systematic Review and Modified Delphi of Global Barriers to Endovascular Therapy.
Stroke
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program
